Quince Therapeutics, Inc. (QNCX) Insider Trading

Name: Quince Therapeutics, Inc. (QNCX) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Jun 15, 2026): Lamond David (Director): Grant/Award of 2,700 shares.

Get alerted when insiders trade QNCX

Email address

Loading company data...

Beta

Loading company details...

Beta